Literature DB >> 15076257

A prospective study of stimulant response in preschool children: insights from ROC analyses.

Elizabeth J Short1, Michael J Manos, Robert L Findling, Emily A Schubel.   

Abstract

OBJECTIVE: The purpose of this study was to examine the efficacy of psychostimulant medication in a naturalistic sample of preschoolers. Benefits and side effects for methylphenidate and mixed amphetamine salts (Adderall) were examined.
METHOD: Twenty-eight preschoolers (ages 4.0 - 5.9) participated in the present investigation. They were obtained consecutively from a large sample of suburban children assessed for attention-deficit/hyperactivity disorder. After having received various dosing levels of a stimulant in a placebo-controlled crossover design, best dose was assigned based on the lowest Abbreviated Symptoms Questionnaire T score received in a given week. All analyses compared best dose ratings to placebo ratings.
RESULTS: Preschoolers' behavioral ratings by parents and teachers were improved as a function of stimulant medication. More than 82% of the medicated sample improved their behavioral rating by at least 1 SD as demonstrated by receiver operating characteristic (ROC) analyses, with more than 50% of medicated preschoolers improving by more than 2 SD. Side effects were infrequent at best dose of medication.
CONCLUSIONS: Clinically significant changes in behavioral ratings of preschoolers were noted in response to stimulant medication. Both stimulants were well tolerated. ROC curves were useful for clearly depicting on a case-by-case basis how much improvement was derived from psychopharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076257     DOI: 10.1097/00004583-200403000-00005

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  12 in total

1.  Interpreting estimates of treatment effects: implications for managed care.

Authors:  Stephen V Faraone
Journal:  P T       Date:  2008-12

Review 2.  Managing attention deficit/hyperactivity disorder: unmet needs and future directions.

Authors:  C R Steer
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

3.  Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.

Authors:  Alain Katic; Bryan Dirks; Thomas Babcock; Brian Scheckner; Ben Adeyi; Cynthia Richards; Robert L Findling
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-08       Impact factor: 2.576

4.  Pharmacotherapy of ADHD in young children.

Authors:  Brigette S Vaughan; Christopher J Kratochvil
Journal:  Psychiatry (Edgmont)       Date:  2006-08

Review 5.  Assessment of attention in preschoolers.

Authors:  E M Mahone; H E Schneider
Journal:  Neuropsychol Rev       Date:  2012-10-23       Impact factor: 7.444

6.  Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.

Authors:  Stephen V Faraone; Jan Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-09-10       Impact factor: 4.785

Review 7.  Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.

Authors:  Jaswinder K Ghuman; L Eugene Arnold; Bruno J Anthony
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

Review 8.  Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.

Authors:  Sharon Wigal; Phillip Chappell; Donna Palumbo; Shannon Lubaczewski; Sara Ramaker; Richat Abbas
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-01-20       Impact factor: 2.576

Review 9.  Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions.

Authors:  Jonathan R Young; Adare Yanagihara; Rachel Dew; Scott H Kollins
Journal:  CNS Drugs       Date:  2021-03-26       Impact factor: 5.749

Review 10.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.